Aplicación del test de caminata de 6 minutos en la valoración del sujeto con EPOC

Harold Fabián Cruz-Bermúdez, Jorge Enrique Moreno-Collazos

Resumen


El test de caminata de 6 minutos, es un instrumento que permite valorar la tolerancia al ejercicio, necesidad de oxígeno suplementario al momento de la actividad física y la respuesta al tratamiento de rehabilitación en sujetos con entidades clínicas cardiacas y pulmonares principalmente; demostrando ser confiable, objetivo, seguro y de bajo costo. Se realiza ordenando al paciente caminar  con una velocidad sostenida por 6 minutos, en un circuito a una distancia conocida; durante la aplicación del test se le hará un continuo monitoreo de funciones vitales, saturación de oxígeno y control de síntomas, adicionalmente, se debe evaluar la magnitud de la disnea empleando la escala de Borg versión modificada, que posee un rango de 0 a 10 puntos, siendo cero la ausencia total de dificultad respiratoria y 10 como nivel máximo. En conclusión el test se utiliza para realizar la comparación de respuesta pre y pos tratamiento de rehabilitación, estado funcional y como predictor de morbilidad y mortalidad. El objetivo del estudio fue realizar una revisión sobre el test de caminata de 6 minutos en sujetos con EPOC.


Palabras clave


Enfermedad pulmonar obstructiva crónica; enfermedades pulmonares; fatiga; rehabilitación; prueba de esfuerzo. (Fuente: DeCS BIREME)

Texto completo:

PDF

Referencias


Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179-91. https://doi.org/10.7326/0003-4819-155-3-201108020-00008

Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-55. https://doi.org/10.1164/rccm.200703-456SO

Killian KJ, Leblanc P, Martín DH, Summers E, Jones NL, Campbell EJ. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow obstruction. Am Rev Respir Dis. 1992; 146: 935-940. https://doi.org/10.1164/ajrccm/146.4.935

Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2010; 91(2):221-5. https://doi.org/10.1016/j.apmr.2009.10.017

Eisner MD1, Iribarren C, Blanc PD, Yelin EH, Ackerson L, Byl N, et al. Development of disability in chronic obstructive pulmonary disease: beyond lung function. Thorax. 2011;66(2):108-14. https://doi.org/10.1136/thx.2010.137661

Man W, Kemp P, Moxham J, Polkey M. Skeletal muscle dysfunction in COPD: Clinical and laboratory observations. Clin Sci (Lond). 2009;117:251-64. https://doi.org/10.1042/CS20080659

Kim H, Mofarrahi M, Hussain S. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3:637-58. https://doi.org/10.2147/COPD.S4480

Man WD, Kemp P, Moxham J, Polkey MI. Exercise and muscle dysfunction in COPD: implications for pulmonary rehabilitation. Clin Sci (Lond). 2009;117(8):281-91. https://doi.org/10.1042/CS20080660

Roca M, Mitu F, Roca IC, Mihăescu T. Body composition alterations in chronic obstructive pulmonary disease. Rev Med Chir Soc Med Nat Iasi. 2013;117(2):337-43.

Roig M, Eng JJ, MacIntyre DL, Road JD, Reid WD. Deficits in muscle strength, mass, quality, and mobility in people with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2011;31(2):120-4. https://doi.org/10.1097/HCR.0b013e3181f68ae4

Cooper KH. A means of assessing maximal oxygen intake: correlation between field and treadmill testing. JAMA. 1968; 203:201–4. https://doi.org/10.1001/jama.1968.03140030033008

Gibbons WJ, Fruchter N, Sloan S, Levy RD. Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years. J Cardiopulm Rehabil. 2001; 21:87-93. https://doi.org/10.1097/00008483-200103000-00005

Rasekaba T, Lee AL, Naughton MT, Williams TJ, Holland AE. The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J. 2009;39(8):495-501. https://doi.org/10.1111/j.1445-5994.2008.01880.x

Lisboa C, Barría P, Yá-ez JV, Aguirre M, Díaz O. La prueba de caminata en seis minutos en la evaluación de la capacidad de ejercicio en pacientes con enfermedad pulmonar obstructiva crónica. Rev Méd Chile. 2008;136:1056-64. https://doi.org/10.4067/S0034-98872008000800015

American Thoracic Society ATS. Statement. Standard for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med. 1995;152:S77-120.

American Thoracic Society ATS. Statement: guidelines for the six-minutes walk test. Am J Resp Crit Care Med. 2002;166:111-7. https://doi.org/10.1164/ajrccm.166.1.at1102

Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932-46. https://doi.org/10.1183/09031936.04.00014304

Hernandes N, Teixeira D, Probst V, Brunetto A, Cipulo Ramos E, Pitta F. Perfil do nível de atividade física na vida diária de pacientes portadores de DPOC no Brasil. J Bras Pneumol. 2009;35(10):949-56. https://doi.org/10.1590/S1806-37132009001000002

Holland AE, Nici L. The return of the minimum clinically important difference for 6-minute-walk distance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(4):335-6. https://doi.org/10.1164/rccm.201212-2191ED

Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, et al. Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med. 2013;187(4):382-6. https://doi.org/10.1164/rccm.201209-1596OC

Waatevik M, Johannessen A, Hardie JA, Bjordal JM, Aukrust P, Bakke PS, et al. Different COPD disease characteristics are related to different outcomes in the 6-minute walk test. COPD. 2012;9(3):227-34. https://doi.org/10.3109/15412555.2011.650240

Chen H, Liang BM, Tang YJ, Xu ZB, Wang K, Yi Q, et al. Relationship between 6-minute walk test and pulmonary function test in stable chronic obstructive pulmonary disease with different severities. Chin Med J (Engl). 2012;125(17):3053-8.

Kulkarni HS, Chandra D, Sciurba FC. Increase in walk distance is not enough evidence to add a walk to the 6-minute walk test. Eur Respir J. 2011;38(5):1239-40. https://doi.org/10.1183/09031936.00113211

Rabinovich RA, Vilaró J, Roca J. Evaluación de la tolerancia al ejercicio en pacientes con EPOC. Prueba de marcha de 6 minutos. Arch Bronconeumol. 2004;40:80-5. https://doi.org/10.1016/S1579-2129(06)60199-7

Tramontini MR, Mayer AF, Cardosoa F, Jardim JR. Variabilidad en las condiciones de la prueba de la marcha realizada en el contexto de programas de rehabilitación pulmonar en América Latina y en la Península Ibérica. Arch Bronconeumol. 2005;41:667-78. https://doi.org/10.1016/S0300-2896(05)70722-5

Criner G. 6-minute walk testing in COPD: is it reproducible? Eur Respir J. 2011;38(2):244-5. https://doi.org/10.1183/09031936.00023011

Ria-o Y, Valbuena LJ. Aplicación de la caminata de 6 minutos en pacientes con enfermedad respiratoria cronica como determinante de la utilidad de un programa de rehabilitacion pulmonar. Umbral Cient. 2010; 16:13 -9.

Almeida F, Victor E, Rizzo J. Hallway versus treadmill 6-minute-walk tests in patients with COPD. Respir care. 2009;54(12):1712-6.

Montero A, Sánchez C, Couti-o LO, Sansores R, Ramírez-Venegas A. Variabilidad de la prueba de caminata de 6 minutos después de eliminar el efecto de aprendizaje en pacientes con enfermedad pulmonar obstructiva crónica. Rev Inst Nal Enf Resp Mex. 2001;14(1);12-5.

Enright P,S. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158:1384-7. https://doi.org/10.1164/ajrccm.158.5.9710086

Holland AE, Hill K, Alison JA, Luxton N, Mackey MG, Hill CJ, et al. Estimating peak work rate during incremental cycle ergometry from the 6-minute walk distance: differences between reference equations. Respiration. 2011;81(2):124-8. https://doi.org/10.1159/000308464

Troosters T, Vilaro J, Rabinovich R, Casas A, Barbera J A, Rodríguez-Roisin R et al. Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease. Eur Respir J. 2002;20:564-9. https://doi.org/10.1183/09031936.02.02092001

de Torres JP, Casanova C, Cote CG, López MV, Díaz O, María Marin J, et al. Six-minute walking distance in women with COPD. COPD. 2011;8(4):300-5. https://doi.org/10.3109/15412555.2011.589870

Spruit MA, Polkey MI, Celli B, Edwards LD, Watkins ML, Pinto-Plata V, et al. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2012;13(3):291-7. https://doi.org/10.1016/j.jamda.2011.06.009

Enfield K, Gammon S, Floyd J, Falt C, Patrie J, Platts-Mills TA, et al. Six-minute walk distance in patients with severe end-stage COPD: association with survival after inpatient pulmonary rehabilitation. J Cardiopulm Rehabil Prev. 2010;30(3):195-202. https://doi.org/10.1097/HCR.0b013e3181c565e4

Beroíza T, Cartagena C, Caviedes I, Céspedes J, Gutiérrez-Navas M, Oyarzún M, et al. Prueba de caminata de seis minutos. Rev. chil. enferm. Respir. 2009; 25(1): 15-24.

Schnaider J, Karsten M. Tolerance tests ti the exercise in a hospital physical therapy program in the exacerbation of the chronic pbstructive pulmonary disease. Fisioter mov. 2006;19(4): 119-26.

González-García M, Barrero M, Maldonado D. Limitación a la tolerancia al ejercicio en pacientes con EPOC a la altura de Bogotá (2640 m). Patrón respiratorio y gasometría arterial en reposo y en ejercicio pico. Arch Bronconeumol. 2004;40:54-61. https://doi.org/10.1157/13056709

Jenkins S, Cecins N. Six-minute walk test: observed adverse events and oxygen desaturation in a large cohort of patients with chronic lung disease. Internal Med. 2011;41:416-22. https://doi.org/10.1111/j.1445-5994.2010.02169.x

Guyatt GH, Pugsley SO, Sullivan MJ, Thompson PJ, Berman L, Jones NL, et al . Effect of encouragement on walking test performance. Thorax. 1984;39:818-22. https://doi.org/10.1136/thx.39.11.818

Lawrence P, Cahalin MA, Michael PT, Marthier A, Semigran MJ, William G, et al. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest. 1996; 110:325-32. https://doi.org/10.1378/chest.110.2.325

Borg G. Psychophysical basis of perceived exertion. Med Sci Sports Exerc. 1982;14: 377-81. https://doi.org/10.1249/00005768-198205000-00012

Hernández R, Ponce E, Aguilar E. Nueva metodología para realizar la prueba de caminata de los 6 minutos. Efdeportes. 2006;11(98). Disponible en: http://www.efdeportes.com/efd98/caminata.htm

Iriberri M, Gáldiz JB, Gorostiza A, Ansola P, Jaca C. Comparison of the distances covered during 3 and 6 min walking test. Respir Med. 2002;96(10):812-6. https://doi.org/10.1053/rmed.2002.1363

Carter R, Holiday DB, Nwasuruba C, Stocks J, Grothues C, Tiep B. 6-minute walk work for assessment of functional capacity in patients with COPD. Chest. 2003;123(5):1408-15. https://doi.org/10.1378/chest.123.5.1408

Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with COPD. Lancet. 1998;351:773-80. https://doi.org/10.1016/S0140-6736(97)03471-5

Mador MJ, Rodis A, Magalang UJ. Reproducibility of Borg scale measurements of dyspnea during exercise in patients with COPD. Chest 1995;107:1590-7. https://doi.org/10.1378/chest.107.6.1590

Crisafulli E, Clini EM. Measures of dyspnea in pulmonary rehabilitation. Multidiscip Respir Med. 2010; 5:202-10. https://doi.org/10.1186/2049-6958-5-3-202

Spence DPS, Hay JG, Carter J, Pearson MG, Calverley PMA. Oxygen desaturation and breathlessness during corridor walking in COPD: effect of oxitropium bromide. Thorax. 1993;48:1145-50. https://doi.org/10.1136/thx.48.11.1145

Simões LA, Dias J, Marinho K, Pinto C, Britto R. Relação da função muscular respiratória e de membros inferiores de idosos comunitários com a capacidade funcional avaliada por teste de caminhada. Rev bras fisioter. 2010; 14(1): 24-30. https://doi.org/10.1590/S1413-35552010000100005

Bernstein ML, Despars JA, Singh NP, Avalos K, Stansbury DW, Light RW. Re-analysis of the 12 minute walk in patients with COPD. Chest. 1994;105:163-7.

https://doi.org/10.1378/chest.105.1.163




DOI: http://dx.doi.org/10.20320/rfcsudes.v1i2.223

Métrica de artículo

Cargando métricas ...

Metrics powered by PLOS ALM


Copyright (c) 2014 Revista Facultad de Ciencias de la Salud UDES

Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento 4.0 Internacional.

....................................................................................................................................................................................................

E-ISSN: 2422-1074